S. Arici Et Al. , "The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment," Colorectal Disease , vol.23, no.1, pp.206-212, 2021
Arici, S. Et Al. 2021. The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment. Colorectal Disease , vol.23, no.1 , 206-212.
Arici, S., HAMDARD, J., Sakin, A., Sengiz Erhan, S., Atci, M. M., Cekin, R., ... Saka, B.(2021). The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment. Colorectal Disease , vol.23, no.1, 206-212.
Arici, Serdar Et Al. "The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment," Colorectal Disease , vol.23, no.1, 206-212, 2021
Arici, Serdar Et Al. "The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment." Colorectal Disease , vol.23, no.1, pp.206-212, 2021
Arici, S. Et Al. (2021) . "The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment." Colorectal Disease , vol.23, no.1, pp.206-212.
@article{article, author={Serdar Arici Et Al. }, title={The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment}, journal={Colorectal Disease}, year=2021, pages={206-212} }